Table 2 Comorbidities in the study population with myasthenia gravis (N = 1149)
From: A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis
Comorbidity | No. of patients (%) | |
|---|---|---|
Baseline (pre-index to index) period | Follow-up (post-index) period | |
Myocardial infarction | 83 (7.2) | 169 (14.7) |
Congestive heart failure | 44 (3.8) | 152 (13.2) |
Peripheral vascular disease | 61 (5.3) | 79 (6.9) |
Cerebrovascular disease | 106 (9.2) | 92 (8.0) |
Dementia | 13 (1.1) | 70 (6.1) |
Chronic pulmonary disease | 129 (11.2) | 236 (20.5) |
Rheumatologic disease | 37 (3.2) | 58 (5.0) |
Peptic ulcer disease | 50 (4.4) | 9 (0.8) |
Mild liver disease | 16 (1.4) | 37 (3.2) |
Moderate or severe liver disease | 3 (0.3) | 13 (1.1) |
Diabetes without chronic complications | 154 (13.4) | 231 (20.1) |
Diabetes with chronic complications | 43 (3.7) | 56 (4.9) |
Hemiplegia or paraplegia | 14 (1.2) | 22 (1.9) |
Renal disease | 128 (11.1) | 265 (23.1) |
Malignancy | 99 (8.6) | 193 (16.8) |
Metastatic solid tumor | 14 (1.2) | 62 (5.4) |
HIV/AIDS | 0 (0.0) | 1 (0.1) |
Hypertension | 437 (38.0) | 172 (15.0) |
Ankylosing spondylitis | 145 (12.6) | 88 (7.7) |
Psoriasis | 50 (4.4) | 25 (2.2) |
Psoriatic arthritis | 3 (0.3) | 6 (0.5) |
Crohn’s disease | 7 (0.6) | 4 (0.3) |
Ulcerative colitis | 10 (0.9) | 12 (1.0) |
Systemic lupus erythematosus | 7 (0.6) | 5 (0.4) |